Orchid Pharma Limited (NSE:ORCHPHARMA)

India · Delayed Price · Currency is INR

991.00

-9.25 (-0.92%)

Jul 31, 2026, 3:30 PM IST

Orchid Pharma Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	8,113	8,113	9,219	8,194	6,659	5,596
Revenue Growth	-12.00%	-12.00%	12.52%	23.05%	19.00%	24.33%
Gross Profit	2,855	2,855	3,548	3,162	2,646	2,325
Operating Income	56.76	56.76	829.5	776.25	289.93	-338.9
Net Income	205.47	205.47	996.57	921.67	463.18	-19.51
Earnings Per Share	4.05	4.05	19.65	19.06	11.35	-0.48
EPS Growth	-79.39%	-79.39%	3.11%	67.93%	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
India	1,809	1,494	1,039	766.14
Rest of the World	7,282	6,658	5,517	4,795
Total	9,091	8,151	6,556	5,561

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	832.11	832.11	211.23	36.16	266.12	43.13
Total Debt	3,626	3,626	1,746	1,352	3,313	2,680
Net Cash (Debt)	-2,794	-2,794	-1,535	-1,316	-3,047	-2,636
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-55.07	-55.07	-30.26	-27.20	-74.66	-64.59

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	1,012	1,012	192.15	1,260	183.38	924.75
Capital Expenditures	-3,836	-3,836	-1,501	-648.15	-849.13	-144.04
Free Cash Flow	-2,824	-2,824	-1,309	611.77	-665.75	780.71
Free Cash Flow Growth	-	-	-	-	-	239.71%

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	35.18%	35.18%	38.48%	38.59%	39.74%	41.55%
Operating Margin	0.70%	0.70%	9.00%	9.47%	4.35%	-6.06%
Pretax Margin	2.51%	2.51%	10.79%	10.87%	7.97%	-10.80%
Profit Margin	2.53%	2.53%	10.81%	11.25%	6.96%	-0.35%
FCF Margin	-34.80%	-34.80%	-14.20%	7.47%	-10.00%	13.95%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 2, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	243.59	119.09	39.50	57.50	33.77	-
Forward PE	61.66	24.18	29.60	41.04	-	-
P/FCF Ratio	-	-	-	86.62	-	14.91
PS Ratio	6.17	3.02	4.27	6.47	2.35	2.08